Integer (NYSE:ITGR) Shares Gap Down - Should You Sell?

Integer Holdings Co. (NYSE:ITGR - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $126.53, but opened at $121.28. Integer shares last traded at $124.59, with a volume of 52,255 shares changing hands.

Analyst Ratings Changes

Several analysts have issued reports on the company. Oppenheimer started coverage on Integer in a research note on Tuesday, July 16th. They issued an "outperform" rating and a $135.00 target price on the stock. KeyCorp boosted their price objective on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. Citigroup increased their target price on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Monday. Finally, Bank of America raised their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Integer currently has an average rating of "Moderate Buy" and a consensus target price of $140.14.

Integer Price Performance

The business's 50-day moving average price is $127.37 and its 200 day moving average price is $120.86. The company has a market capitalization of $4.25 billion, a P/E ratio of 43.86, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $1.27 EPS. Analysts anticipate that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Jean M. Hobby sold 11,960 shares of the firm's stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares of the company's stock, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Guidance Capital Inc. purchased a new stake in Integer in the first quarter worth approximately $500,000. Congress Wealth Management LLC DE grew its holdings in shares of Integer by 7.6% during the 1st quarter. Congress Wealth Management LLC DE now owns 69,328 shares of the medical equipment provider's stock valued at $8,089,000 after purchasing an additional 4,873 shares during the last quarter. AlphaMark Advisors LLC purchased a new position in Integer in the 1st quarter worth $359,000. Tributary Capital Management LLC lifted its stake in Integer by 1.2% in the first quarter. Tributary Capital Management LLC now owns 285,677 shares of the medical equipment provider's stock worth $33,333,000 after purchasing an additional 3,513 shares during the last quarter. Finally, Azzad Asset Management Inc. ADV boosted its position in Integer by 7.9% during the first quarter. Azzad Asset Management Inc. ADV now owns 7,772 shares of the medical equipment provider's stock valued at $907,000 after buying an additional 566 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.